Profile of prophylactic analyzes |
Complete Blood Count + Erythrocyte sedimentation rate |
Uric Acid |
Creatinine |
Creatinine in urine |
Triglycerides |
Glucose |
Bilirubin Total |
Total Cholesterol |
Alanine aminotransferase |
Aspartate aminotransferase |
Thyrotropic hormone |
General clinical tests |
Complete Blood Count +Erythrocyte sedimentation rate |
Blood group and Rhesus determination |
Urinalysis |
Urine Bacteriology |
Protein in ureaProtein in urea |
Pap test |
Gynecological smear analys |
Reticulocyte |
Determination of Rhesus antibodies |
Spermogram |
Sperm bacteriology |
Bacteriology of prostate secretion |
General analysis of feces |
Fecal occult blood test |
Bacteriological examination of feces |
Dysbacteriosis |
Examining the fecal mass for worm eggs |
Hemostasis |
Coagulogram |
Prothrombin, international normalized ratio |
D-D- dimer |
Lupus Anticoagulant |
Antithrombin III |
Coagulogram |
Prothrombin, international normalized ratio |
Activated partial thromboplastin time |
Thrombin time |
Fibrinogen |
Blood biochemistry |
C reactive protein |
Rheumatoid factor |
Antistreptolysin |
CortisolCortisol |
Cortisol 24 h Urine |
Total Bilirubin |
Direct Bilirubin |
Alanine aminotransferase |
Aspartate aminotransferase |
Gammaglutamyltransferase |
Alkaline phosphatase |
Bone-specific Alkaline Phossphatase |
Total Cholesterol |
High density lipoproteins |
low density lipoproteins |
very low density lipoproteins |
Triglycerides |
Atherogenic Index |
Glucose |
Urea |
Creatinine |
Creatinine in urine |
IHigh sensitivity Troponin I |
MBCK MB |
CKL |
Albumin |
Total Protein |
Ammonia |
Uric Acid |
Lipase |
Amylase |
Amylase |
total Calcium |
Iron |
iron binding capacity |
TransferinTransferin |
Sodium |
Phosphorus |
Magnesium |
ClChlorine |
(Na.K.Ca)Electrolytes |
Ionized calcium |
Potassium |
Glycosylated hemoglobin |
Lactate dehydrogenase |
Renin |
Aldosteron |
Profile of liver function tests |
Total Bilirubin |
Direct Bilirubin |
Alanine aminotransferase |
Aspartate aminotransferase |
Gammaglutamyltransferase |
Alkaline phosphatase |
Lipid metabolism profile |
Total Cholesterol |
High density lipoproteins |
low density lipoproteins |
very low density lipoproteins |
Triglycerides |
Atherogenic Index |
Profile of renal function |
Urea |
Creatinine |
Uric Acid |
Imunology |
Antimuller |
Prostate-specific antigen |
Determination of the concentration of cancer antigen CA125 |
Determination of carbohydrate antigen concentrationСА-19-9) |
Determination of carbohydrate antigen concentrationСА-15-3) |
CEA |
Epstein-Barr virus panel |
Helicobacter pylori rapid test |
Thyrotropic hormone |
Free triiodothyronine |
triiodothyronine |
Free thyroxine |
thyroxine |
Antibodies to thyroglobulin |
thyroglobulin |
Antibodies to thyroperoxidase |
PTHPTH |
Maluteinized hormone |
Follicle-stimulating hormone |
17-OHprogesterone 17-Oh |
prolactine |
free testosterone |
testosterone |
Beta-Chorionic gonadotropin |
Alpha-fetoprotein |
Estradiol |
Free estriol |
VITAMIN D |
FERRITIN |
VITAMIN B12 |
Folate |
(C-Peptide) HOMA INDEX |
(insulin) HOMA INDEX |
Procalcitonin |
Calcitonin |
Insulin |
C-peptide |
Progesteron |
PAPP-A |
Growth Hormone Tests |
Insulin-like Growth Factor 1 |
Triple screening test |
Estriol |
Beta-Chorionic gonadotropin |
Alpha-fetoprotein |
Double screening test |
A Determination of plasma protein A associated with pregnancy |
Free beta-chorionic gonadotropin |
Panel of thyroid hormones |
Thyrotropic hormone |
Free triiodothyronine |
Free thyroxine |
Antibodies to thyroglobulin |
Antibodies to thyroperoxidase |
sex hormones |
Maluteinized hormone |
Follicle-stimulating hormone |
17-OHProgesterone 17-OH |
Progesteron |
Prolactin |
Free testosterone |
Testosterone |
Estradiol |
-Dehydroepiandrosterone-sulfate |
Antiphospholipid syndrome |
IgMAnticardiolipins IgM |
IgGAnticardiolipins IgG |
Beta 2 glycoprotein IgG |
Beta 2 glycoprotein IgM |
Lupus anticoagulant |
Antiphospholipids IgM |
Antiphospholipids IgG |
Serological test |
Homocysteine |
S protein |
C protein |
MEASLES IgG |
MEASLES IgM |
Rubella IgG |
Rubella IgM |
Toxoplasma gondi antibodies Ig G |
Toxoplasma gondi antibodies Ig M |
Herpes simplex virus antibodies Ig G |
Herpes simplex virus antibodies IgM |
Antibodies to cytomegalovirus Ig M |
Antibodies to cytomegalovirus Ig G |
Chlamydia trachoma Anti-Ig antibodies |
Chlamydia trachoma Anti-IgG antibodies |
Hepatitis B. |
Hepatitis C. |
HIV infection |
Syphilis |
Epstein-Barr virus Anti-IgM Quantitative Analysis |
Epstein-Barr virus Anti-IgG Quantitative Analysis |
Total IgE Quantitative Analysis |
Total IgA |
Total IgM |
Total IgG |
Interleukin 6 Human ELISA |
Antispermal Antibodies (ASA) |
anti-Borellia IgM |
anti-Borellia IgG |
Antinuclear Antibody |
Anti-dsDNA Antibody |
Anti-cyclic citrullinated peptides |
TORCH- Profile of TORCH infections |
Toxoplasma gondi antibodies Ig G |
Toxoplasma gondi antibodies Ig M |
Herpes simplex virus antibodies Ig G |
Herpes simplex virus antibodies IgM |
Antibodies to cytomegalovirus Ig M |
Antibodies to cytomegalovirus Ig G |
Chlamydia trachomatis-IgM antibodies |
Chlamydia trachomatis Anti-IgG antibodies |
Preeclampsia Screening |
Real-Time PCR analysis of Sexually transmitted Infections |
Gardnerella vaginalis |
Chlamydia Trachomatis |
Neisseria Gonorrhoeae |
Trichomonas Vaginalis |
Ureaplasma Urealyticum/Parvum |
С.trachomatis/Ureapl./M.hominis/M.genitalium RealTM |
С.trachomatis/ Ureapl./ M.hominis/ M.genitalium/ N.Gonorrhoeae/ T. Vaginalis RealTM |
Mycoplasma Hominis |
Mycoplasma Genitalium |
T. vaginalis/N.gonorrhoeae/Chl.trachomatis |
Chlamydia Trachomatis/Mycoplasma Genitalium/Ureaplasma spp. |
Gardnerella Vaginalis/ Lactobacillius spp. |
Toxoplasma Gondii |
Treponema Pallidum |
Candida Albicans |
Human Herpes Simplex Type 1 |
Human Herpes Simplex Type 2 |
Human Herpes Simplex Type 1/2 |
quantitative detection of Cytomegalovirus (CMV), Epstein Barr Virus (EBV) and Human Herpes 6 Virus (HHV6) |
Diagnostic of respiratory viruses |
RT-PCR analysis of influenza type A/B and syncytial virus (HRSV). |
Molecular diagnostic of hepatitis virus |
Quantitative PCR analysis of hepatitis B virus (HBV). |
Quantitative PCR analysis of hepatitis C virus (HCV). |
Qualitative PCR analysis of hepatitis B virus (HBV). |
Qualitative PCR analysis of hepatitis C virus (HCV). |
Streptococcus B RT-PCR diagnosis |
Real Time PCR for quantitative detection of Streptococcus agalactiae |
Bacterial Vaginosis RT-PCR Diagnosis |
Gardnerella vaginalis, Atopobium vaginae, Lactobacillus spp. and total bacteria quantity |
Chronic prostatitis RT-PCR diagnosis |
Detection of Enterobacter spp., Klebsiella spp., Enterococcus faecalis, Е. faecium, Escherichia coli, Proteus spp., Pseudomonas aeruginosa, Serratia spp., Staphylococcus aureus, Streptococcus spp. |
Detection of Human Papillomavirus (HPV) by RT-PCR |
High Risk Human Papillomavirus (HPV) Genotyping test ( 16, 18, 31, 33, 39, 35, 45, 51, 52, 56, 58, 59, 66, 68) |
High and Low Risk Human Papillomavirus(HPV) Genotyping test (6, 11, 44)(16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, |
Molecular Diagnosis of Solid Tumors |
Molecular Diagnostic panel for Thyroid Cancer: BRAF (5 mutations),KRAS (4 mutations), NRAS (5 mutations) |
Molecular Diagnostic Panel for Melanoma : BRAF(V600E; V600E complex; V600K; V600D; V600R) |
BRAF(V600E; V600E complex; V600K; V600D; V600R) |
Molecular Diagnostic Panel for Colorectal Cancer: BRAF (5 mutations),KRAS (4 mutations), NRAS (5 mutations) |
Molecular Diagnostic Panel for Lung Cancer: EGFR (L858R; T790M, Ex19del) |
Molecular Genetic test for Pancreatic Cancer (CDKN2A, CDKN2B, CDK4, MITF) |
Molecular Genetic Analysis of Lynch Syndrome |
Molecular Genetic Analysis of Li-Fraumen Syndrome – Genetically heterogeneous inherited cancer syndrome |
Molecular Diagnosis of hereditary breast and ovarian cancer |
Fragment Analysis of genes associated with Breast and Ovarian Cancer: BRCA1, BRCA2/CHEK2 |
MammaTyper TEST, |
ROMA ROMA Index |
Single Gene Mutational Analysis by RT-PCR |
Mutation Analysis of BRAF gene (V600E/K/D/R/E complex) |
PDL-1 Gene Expression analysis |
Mutation Analysis of PDGFRA gene |
Mutation Analysis of TP53 gene (7 mutations) |
Mutation Analysis of JAK2 gene (V617F) |
Mutation Analysis of KRAS gene (4 mutation), NRAS gene (5 mutation) |
Molecular Diagnosis of Leukemia By MLPA |
Diagnostic Panel I for Myeloproliferative Neoplasms : JAK2 (V617F, N542_E543DEL, E543_D544DEL); MPL (W515K, W515L); CARL (L367fs*46, K385fs*47); KIT (D816V) Fragment analysis |
Diagnostic Panel II for Myeloproliferative Neoplasms : |
JAK2 (V617F); MPL (W515K, W515L); KIT (D816V) RT-PCR |
5 Minimal Residual Disease and Drug Resistance Diagnostic Panel III: BCR-ABL p.210 qPCR, ABL gene mutations |
Diagnostic and prognostic panel (IPSS-R) for Myelodysplastic Syndrome: JAK2 p.V617F; EGR1, MIR145, SPARC, MIR146A, EZH2, MYC, KMT2A, ETV6; TP53, NF1, SUZ12; ASXL1; Y-Chromosome |
Diagnostic Panel for Myelodysplastic Syndrome and Acute Myeloid Leukemia(MDS-AML): GATA2; TERC; TERT; CEBPA; RUNX1 |
Diagnostic Panel for Chronic Myeloid Leukemia(CML): CDKN2A/B; TP53; PTEN; ATM; RB1; DLEU1/2; NOTCH1; SF3B1; MYD88; MYCN; ALK; REL; TNFAIP3; TNFRSF10A/B; EIF3H; MYC; MIR15A |
CD27; CDKN2A/B; TP53; PTEN; ATM; RB1; DLEU1/2; NOTCH1; SF3B1; MYD88; MYCN; ALK; REL; TNFAIP3; TNFRSF10A/B; EIF3H; MYC; MIR15A |
Diagnostic Panel for Acute Myelogenous Leukemia (AML) EBF1; CDKN2A/B; PAX5; ETV6; BTG1; RB1; PAR1 |
Quantitative Analysis of the BCR-ABL fusion gene: BCR-ABL1 p190 |
Quantitative Analysis of the BCR-ABL fusion gene: BCR-ABL1 p210 |
Qualitative Analysis of the BCR-ABL fusion gene : BCR-ABL1 p210, BCR-ABL1 p190, BCR-ABL1 p230, BCR-ABL1 p195 |
Detection of mutations in ABL gene asscociated with TKI theraphy resistance |
Genetic Thrombophilia RT-PCR Testing |
FACTOR V LEIDEN (G1691A) |
FACTOR V (H1299R) |
FII (G20210A)(PROTHROMBIN) |
MTHFR (A1298C) |
MTHFR (C6777T) |
PAI-1 |
Analysis of individual gene of Thrombophilia Diagnostic panel |
Cardio Thrombophilia RT-PCR Testing |
FII (G20210A)(PROTHROMBIN) |
FACTOR V LEIDEN (G1691A) |
FVII 10976 G>A (Arg353Gln) |
FXIII G>T (Val34Leu) |
FGB -455 G>A |
ITGA2 807 C>T (Phe224Phe) |
ITGB3 1565 T>C (Leu33Pro) |
PAI-1 -675 5G>4G |
RT-PCR Diagnosis of folate metabolism |
MTRR (A 66 G) |
MTR (A2756G) |
MTHFR (A1298C) |
MTHFR (C6777T) |
Molecular Dignosis of Haemoglobin Disorders |
β thalassemia Genetic Tetsing |
α thalassemia Genetic Tetsing |
Sickle Cell Anemia Genetic Tetsing |
11 Molecular Testing of Genetic Disorders |
11 Genetic analysis of 11 mutations ascociated with Periodic Disease (Famillial Mediterranean Fevere (FMF)) |
X-Fragile X Genetic Testing |
Molecular-Genetic Teting of phenylalanine hydroxylase deficiency (phenylketonuria (PKU)) |
(SMN1,SMN2)Newborn Screening: Spinal Muscular Atrophy (SMA) |
(SMN1,SMN2, NAIP)Confirmatory test of Spinal Muscular Atrophy (SMA) diagnosis and Carrier Testing |
Molecular Genetic Analysis of Hunter Syndrome (Type II mucopolysaccharidosis) |
Molecular Genetic Analysis of Cystic Fibrosis (Mucoviscidosis) |
Molecular Genetic Analysis of MODY types 1,2,3 and 5 |
Molecular Genetic Analysis of MODY types 4,6,7,8,9 and 10 |
Fragment Analysis of PSEN1, PSEN2, APP genes associated with Early-Onset Familial Alzheimer Disease (EOFAD) |
Fragment Analysis of genes associated with Genetic Obesity: LEPR, POMC, SIM1, LEP, MC4R, MC2R and MC3R |
LEPR, POMC, SIM1, LEP, MC4R, MC2R and MC3R |
Celiac Disease Genetic Testing (HLA-DQ) |
Fragment analisys of genes associated with familial Hypertrophic cardiomyopathy familial and Dilated cardiomyopathy |
Fragment analisys of genes associated familial Hypercholesterolemia |
RT-PCR LDLR 19p13.2: 1- 18- ; APOB: rs5742904, rs12713559, rs144467873, rs13306187, rs12720772, rs57825321, rs41291161; PCSK9 : rs565436, rs28362269, rs764603059, rs148562777, rs565436, rs28362269 |
Fragment analisys of genes associated with Long QT syndrome (KCNQ1; KCNH2; KCNE1; KCNE2; KCNJ2) |
Fragment analisys of genes associated Brugada syndrome and long QTS (SCN5A) |
Aneuploidy Prenatal and Postnatal Screening |
Patau syndrome(47,XY,+13); Edwards syndrome(47, XY,+18); Down syndrome(47, XY, +21); Turner syndrome(45,X0); Triple X syndrome(47, XXX); Klinefelter syndrome(47, XXY); XYY syndrome(47, XYY); Triploid female(69, XXX); Triploid male(69,XXY); Triploid male(69, XYY) |
Genetic testing of aborted sample |
Patau syndrome(47,XY,+13); Edwards syndrome(47, XY,+18); Down syndrome(47, XY, +21); Turner syndrome(45,X0); Triple X syndrome(47, XXX); Klinefelter syndrome(47, XXY); XYY syndrome(47, XYY); Triploid female(69, XXX); Triploid male(69,XXY); Triploid male(69, XYY) |
Y Chromosome Microdeletion assay (Oligozoospermia and Azoospermia Diagnosis) |
Fragment Analysis of Azoospermia factors associated with spermatogenetic failure: AZFa, AZFb; AZFc (55 mutations) |
Y Chromosome Microdeletion RT-PCR analysis |
Real Time PCR test for detection of the microdeletions in AZF regions: AZFa (sY84, sY86), AZFb (sY127, sY134), AZFc (sY254, sY255) |
Nutrigenetics – Nutri DNA Test |
Covid 19 Diagnostic Assay |
Covid 19 PCR Test |
Covid 19 Rapid Antigen Test |
Covid 19 Rapid Antibody Test |
Covid 19 quantitative Antibody Test (ELISA Method) |
Covid 19 Delta strain RT-PCR Test |
Covid 19 Omicron RT-PCR Test |